Skip to main content
Top
Published in: Digestive Diseases and Sciences 2/2019

01-02-2019 | Original Article

Epidemiological Trends in Gastrointestinal Cancers in China: An Ecological Study

Authors: Liting Xi, Jinzhou Zhu, Huixian Zhang, Merlin Muktiali, Chunfang Xu, Airong Wu

Published in: Digestive Diseases and Sciences | Issue 2/2019

Login to get access

Abstract

Background

In recent decades, the patterns and trends of gastrointestinal (GI) cancer epidemics in Chinese population have been changing.

Aims

To present the epidemiological trends and geographic distributions of four major GI cancers (esophageal cancer, stomach cancer, liver cancer and colorectal cancer) in China from 2010 to 2014.

Methods

It used standardized data extracted from the National Central Cancer Registry database.

Results

The age-standardized incidence rates (ASIR) of esophageal cancer decreased from 16.7 to 12.2 per 100,000 and the age-standardized mortality rates (ASMR) decreased from 12.0 to 8.8 per 100,000. The ASIR and the ASMR of stomach cancer dropped from 23.7 to 19.5 per 100,000 and from 16.6 to 13.3 per 100,000. The ASIR of liver cancer fell from 21.4 to 17.8 per 100,000 and its ASMR fell from 18.4 per 100,000 to 15.3 per 100,000. The ASIR of colorectal cancer increased from 16.1 to 17.5 per 100,000, whereas the ASMR fluctuated between 7.6 and 7.9 per 100,000. Moreover, the incidence and mortality of each cancer differed between males and females, urban and rural residence, as well as various regions.

Conclusion

From 2010 to 2014, esophageal cancer, stomach cancer and liver cancer showed downward trend, while the ASIR of colorectal cancer slightly rose and its ASMR presented stable.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018.
2.
go back to reference Chen W, Zheng R, Zhang S, et al. Cancer incidence and mortality in China, 2013. Cancer Lett. 2017;401:63–71.CrossRefPubMed Chen W, Zheng R, Zhang S, et al. Cancer incidence and mortality in China, 2013. Cancer Lett. 2017;401:63–71.CrossRefPubMed
3.
go back to reference Chen W, Zheng R, Zhang S, Zhao P, Zeng H, Zou X. Report of cancer incidence and mortality in China, 2010. Ann Transl Med. 2014;2:61.PubMedPubMedCentral Chen W, Zheng R, Zhang S, Zhao P, Zeng H, Zou X. Report of cancer incidence and mortality in China, 2010. Ann Transl Med. 2014;2:61.PubMedPubMedCentral
4.
go back to reference Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115–132.CrossRefPubMed Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115–132.CrossRefPubMed
5.
go back to reference Costa NR, da Costa RMG, Medeiros R. A viral map of gastrointestinal cancers. Life Sci. 2018;199:188–200.CrossRefPubMed Costa NR, da Costa RMG, Medeiros R. A viral map of gastrointestinal cancers. Life Sci. 2018;199:188–200.CrossRefPubMed
6.
go back to reference Prabhu A, Obi KO, Rubenstein JH. The synergistic effects of alcohol and tobacco consumption on the risk of esophageal squamous cell carcinoma: a meta-analysis. Am J Gastroenterol. 2014;109:822–827.CrossRefPubMed Prabhu A, Obi KO, Rubenstein JH. The synergistic effects of alcohol and tobacco consumption on the risk of esophageal squamous cell carcinoma: a meta-analysis. Am J Gastroenterol. 2014;109:822–827.CrossRefPubMed
8.
go back to reference Dong J, Thrift AP. Alcohol, smoking and risk of oesophago-gastric cancer. Best Pract Res Clin Gastroenterol. 2017;31:509–517.CrossRefPubMed Dong J, Thrift AP. Alcohol, smoking and risk of oesophago-gastric cancer. Best Pract Res Clin Gastroenterol. 2017;31:509–517.CrossRefPubMed
9.
go back to reference Liu Z, Talukdar FR, Ghosh SK, Laskar RS, Mondal R. Epigenetic, genetic and environmental interactions in esophageal squamous cell carcinoma from northeast India. PLoS One. 2013;8:e60996.CrossRef Liu Z, Talukdar FR, Ghosh SK, Laskar RS, Mondal R. Epigenetic, genetic and environmental interactions in esophageal squamous cell carcinoma from northeast India. PLoS One. 2013;8:e60996.CrossRef
10.
go back to reference Lima SCS, Hernández-Vargas H, Simão T, et al. Identification of a DNA methylome signature of esophageal squamous cell carcinoma and potential epigenetic biomarkers. Epigenetics. 2014;6:1217–1227.CrossRef Lima SCS, Hernández-Vargas H, Simão T, et al. Identification of a DNA methylome signature of esophageal squamous cell carcinoma and potential epigenetic biomarkers. Epigenetics. 2014;6:1217–1227.CrossRef
11.
go back to reference Mani S, Szymańska K, Cuenin C, et al. DNA methylation changes associated with risk factors in tumors of the upper aerodigestive tract. Epigenetics. 2014;7:270–277.CrossRef Mani S, Szymańska K, Cuenin C, et al. DNA methylation changes associated with risk factors in tumors of the upper aerodigestive tract. Epigenetics. 2014;7:270–277.CrossRef
12.
13.
go back to reference Yang CS. Research on esophageal cancer in China: a review. Cancer Res. 1980;40:2633–2644.PubMed Yang CS. Research on esophageal cancer in China: a review. Cancer Res. 1980;40:2633–2644.PubMed
14.
go back to reference Lagergren J, Lagergren P. Recent developments in esophageal adenocarcinoma. CA Cancer J Clin. 2013;63:232–248.CrossRefPubMed Lagergren J, Lagergren P. Recent developments in esophageal adenocarcinoma. CA Cancer J Clin. 2013;63:232–248.CrossRefPubMed
15.
go back to reference Zeng H, Chen W, Zheng R, et al. Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries. Lancet Global Health. 2018;6:e555–e567.CrossRefPubMed Zeng H, Chen W, Zheng R, et al. Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries. Lancet Global Health. 2018;6:e555–e567.CrossRefPubMed
16.
go back to reference Chen W, Zeng H, Chen R, et al. Evaluating efficacy of screening for upper gastrointestinal cancer in China: a study protocol for a randomized controlled trial. Chin J Cancer Res. 2017;29:294–302.CrossRefPubMedPubMedCentral Chen W, Zeng H, Chen R, et al. Evaluating efficacy of screening for upper gastrointestinal cancer in China: a study protocol for a randomized controlled trial. Chin J Cancer Res. 2017;29:294–302.CrossRefPubMedPubMedCentral
19.
go back to reference Tian D, Mo S-J, Han L-K, et al. Investigation of dietary factors and esophageal cancer knowledge: comparison of rural residents in high- and low-incidence areas. Sci Rep. 2018;8:4914.CrossRefPubMedPubMedCentral Tian D, Mo S-J, Han L-K, et al. Investigation of dietary factors and esophageal cancer knowledge: comparison of rural residents in high- and low-incidence areas. Sci Rep. 2018;8:4914.CrossRefPubMedPubMedCentral
20.
21.
go back to reference Buckland G, Travier N, Huerta JM, et al. Healthy lifestyle index and risk of gastric adenocarcinoma in the EPIC cohort study. Int J Cancer. 2015;137:598–606.CrossRefPubMed Buckland G, Travier N, Huerta JM, et al. Healthy lifestyle index and risk of gastric adenocarcinoma in the EPIC cohort study. Int J Cancer. 2015;137:598–606.CrossRefPubMed
22.
go back to reference Leung WK, Wu M-S, Kakugawa Y, et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 2008;9:279–287.CrossRefPubMed Leung WK, Wu M-S, Kakugawa Y, et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 2008;9:279–287.CrossRefPubMed
23.
go back to reference Yao X-Q, Chen X-Z, Huang C-Z, Hu W-X, Liu Y. Gastric cancer screening by combined determination of serum helicobacter pylori antibody and pepsinogen concentrations: ABC method for gastric cancer screening. Chin Med J. 2018;131:1232.CrossRefPubMedPubMedCentral Yao X-Q, Chen X-Z, Huang C-Z, Hu W-X, Liu Y. Gastric cancer screening by combined determination of serum helicobacter pylori antibody and pepsinogen concentrations: ABC method for gastric cancer screening. Chin Med J. 2018;131:1232.CrossRefPubMedPubMedCentral
24.
go back to reference Wang F, Meng W, Wang B, Qiao L. Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer Lett. 2014;345:196–202.CrossRefPubMed Wang F, Meng W, Wang B, Qiao L. Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer Lett. 2014;345:196–202.CrossRefPubMed
25.
go back to reference Sitarz R, Skierucha M, Mielko J, Offerhaus J, Maciejewski R, Polkowski W. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res. 2018;10:239–248.CrossRefPubMedPubMedCentral Sitarz R, Skierucha M, Mielko J, Offerhaus J, Maciejewski R, Polkowski W. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Manag Res. 2018;10:239–248.CrossRefPubMedPubMedCentral
26.
go back to reference Shen L, Shan Y-S, Hu H-M, et al. Management of gastric cancer in Asia: resource-stratified guidelines. Lancet Oncol. 2013;14:e535–e547.CrossRefPubMed Shen L, Shan Y-S, Hu H-M, et al. Management of gastric cancer in Asia: resource-stratified guidelines. Lancet Oncol. 2013;14:e535–e547.CrossRefPubMed
27.
go back to reference Long B, Yu Z-Y, Li Q, et al. A systematic review and network meta-analysis protocol of neoadjuvant treatments for patients with gastric cancer. Medicine. 2018;97:e0392.CrossRefPubMedPubMedCentral Long B, Yu Z-Y, Li Q, et al. A systematic review and network meta-analysis protocol of neoadjuvant treatments for patients with gastric cancer. Medicine. 2018;97:e0392.CrossRefPubMedPubMedCentral
28.
go back to reference Fu J, Wang H. Precision diagnosis and treatment of liver cancer in China. Cancer Lett. 2018;412:283–288.CrossRefPubMed Fu J, Wang H. Precision diagnosis and treatment of liver cancer in China. Cancer Lett. 2018;412:283–288.CrossRefPubMed
29.
go back to reference Chen JG, Zhang SW. Liver cancer epidemic in China: past, present and future. Semin Cancer Biol. 2011;21:59–69.CrossRefPubMed Chen JG, Zhang SW. Liver cancer epidemic in China: past, present and future. Semin Cancer Biol. 2011;21:59–69.CrossRefPubMed
30.
go back to reference Liang X, Bi S, Yang W, et al. Epidemiological serosurvey of Hepatitis B in China: declining HBV prevalence due to Hepatitis B vaccination. Vaccine. 2009;27:6550–6557.CrossRefPubMed Liang X, Bi S, Yang W, et al. Epidemiological serosurvey of Hepatitis B in China: declining HBV prevalence due to Hepatitis B vaccination. Vaccine. 2009;27:6550–6557.CrossRefPubMed
31.
go back to reference Zu J, Zhuang G, Liang P, et al. Estimating age-related incidence of HBsAg seroclearance in chronic hepatitis B virus infections of China by using a dynamic compartmental model. Sci Rep. 2017;7:2912.CrossRefPubMedPubMedCentral Zu J, Zhuang G, Liang P, et al. Estimating age-related incidence of HBsAg seroclearance in chronic hepatitis B virus infections of China by using a dynamic compartmental model. Sci Rep. 2017;7:2912.CrossRefPubMedPubMedCentral
32.
go back to reference Tsochatzis EA, Meyer T, Burroughs AK. Hepatocellular carcinoma. N Engl J Med. 2012;83:693. Tsochatzis EA, Meyer T, Burroughs AK. Hepatocellular carcinoma. N Engl J Med. 2012;83:693.
33.
go back to reference Chen JG, Lu JH, Zhang YH, Wang JB, Zhu J, Zhu YR. Progress and application of alpha-fetoprotin for screening. China Cancer. 2009;18:609–612. Chen JG, Lu JH, Zhang YH, Wang JB, Zhu J, Zhu YR. Progress and application of alpha-fetoprotin for screening. China Cancer. 2009;18:609–612.
34.
go back to reference Liu W, Liu Q, Huang Q, et al. Time trend analysis of primary liver cancer incidence in Sihui county of Guangdong Province, China (1987–2011). BMC Cancer. 2016;16:796.CrossRefPubMedPubMedCentral Liu W, Liu Q, Huang Q, et al. Time trend analysis of primary liver cancer incidence in Sihui county of Guangdong Province, China (1987–2011). BMC Cancer. 2016;16:796.CrossRefPubMedPubMedCentral
36.
go back to reference Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67:177–193.CrossRefPubMed Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67:177–193.CrossRefPubMed
38.
go back to reference Corley DA, Jensen CD, Marks AR, et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014;370:2539–2540.CrossRef Corley DA, Jensen CD, Marks AR, et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014;370:2539–2540.CrossRef
39.
go back to reference Kerr J, Anderson C, Lippman SM. Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidence. Lancet Oncol. 2017;18:e457–e471.CrossRefPubMed Kerr J, Anderson C, Lippman SM. Physical activity, sedentary behaviour, diet, and cancer: an update and emerging new evidence. Lancet Oncol. 2017;18:e457–e471.CrossRefPubMed
40.
go back to reference Schreuders EH, Ruco A, Rabeneck L, et al. Colorectal cancer screening: a global overview of existing programmes. Gut. 2015;64:1637–1649.CrossRefPubMed Schreuders EH, Ruco A, Rabeneck L, et al. Colorectal cancer screening: a global overview of existing programmes. Gut. 2015;64:1637–1649.CrossRefPubMed
41.
go back to reference Deng SX, Gao J, An W, et al. Colorectal cancer screening behavior and willingness: an outpatient survey in China. World J Gastroenterol. 2011;17:3133–3139.PubMedPubMedCentral Deng SX, Gao J, An W, et al. Colorectal cancer screening behavior and willingness: an outpatient survey in China. World J Gastroenterol. 2011;17:3133–3139.PubMedPubMedCentral
42.
go back to reference Gong Y, Peng P, Bao P, et al. The implementation and first-round results of a community-based colorectal cancer screening program in Shanghai, China. Oncologist. 2018;23:928–935.CrossRefPubMedPubMedCentral Gong Y, Peng P, Bao P, et al. The implementation and first-round results of a community-based colorectal cancer screening program in Shanghai, China. Oncologist. 2018;23:928–935.CrossRefPubMedPubMedCentral
Metadata
Title
Epidemiological Trends in Gastrointestinal Cancers in China: An Ecological Study
Authors
Liting Xi
Jinzhou Zhu
Huixian Zhang
Merlin Muktiali
Chunfang Xu
Airong Wu
Publication date
01-02-2019
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 2/2019
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-5335-6

Other articles of this Issue 2/2019

Digestive Diseases and Sciences 2/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.